Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Natural Grocers by Vitamin Cottage Q2 FY2026 Earnings Call - Comps Miss, ERP Upgrade Complete, Guidance Tightens
Natural Grocers delivered a mixed second quarter, with comparable store sales ticking up just 0.5% against a 8.9% surge a year ago. The number tells a story of consumer fatigue. Basket size grew 1.6%,...
- Comparable store sales grew just 0.5%, a sharp deceleration from 8.9% a year ago, signaling consumer fatigue in a value-seeking environment.
- Daily average comps were driven by a 1.6% increase in basket size, while transaction counts declined 1.1%, showing shoppers buying more per trip but visiting less often.
- nPower Rewards membership penetration surged 300 basis points to 84%, proving the loyalty program is the core engine of revenue and a critical buffer against economic uncertainty.
- +9 more takeaways
ICU Medical Q1 2026 Earnings Call - Core Businesses Grow as Tariff Headwinds Offset by Efficiency Gains
ICU Medical delivered a mixed Q1 2026 report where organic growth remained steady despite macroeconomic noise. Revenue came in at $526 million, up 1% organically but down 12% reported due to the decon...
- Total revenue was $526 million, reflecting 1% organic growth but a 12% reported decline due to the deconsolidation of the IV Solutions business into an Otsuka joint venture.
- Adjusted gross margins expanded to 41%, beating expectations, driven by favorable product mix and the exit of lower-margin business segments.
- Adjusted EBITDA held steady at $99 million year-over-year, while adjusted EPS rose 15% to $1.97, supported by cost discipline and mix improvement.
- +7 more takeaways
Xponential Fitness Q1 2026 Earnings Call - Same-Store Sales Dip 6% Amid Digital Ad Shifts, But Management Reaffirms 2026 Guidance and Highlights Retention Strength
Xponential Fitness reported a 6% decline in Q1 2026 same-store studio sales, driven by a tough year-over-year comparison and structural headwinds in digital advertising. Meta’s transition to an AI-dri...
- Same-store studio sales declined 6% overall in Q1 2026, with Club Pilates down 4%, against a tough 9% growth comparison from Q1 2025.
- Member retention improved 36 basis points year-over-year, marking the best retention month since Q1 2024, with Club Pilates 3-year LTV exceeding $2,300.
- Digital advertising headwinds from Meta’s AI-driven Andromeda platform and Google’s AI-generated search results reduced organic traffic and lead flow.
- +7 more takeaways
GSI Technology Q4 FY2026 Earnings Call - SRAM Cash Engine Funds Gemini-II Edge AI Push
GSI Technology closed fiscal 2026 with $25.1 million in revenue, a 22.4% year-over-year jump driven by a resilient SRAM business that now funds its ambitious APU roadmap. The company is pivoting from ...
- Fiscal 2026 revenue reached $25.1 million, up 22.4% year-over-year, anchored by strong demand in the SRAM segment for AI chip development and simulation.
- Gross margins expanded significantly to 54.5% from 49.4% in the prior year, driven by a favorable product mix and increased SRAM sales.
- The company maintains a fortress balance sheet with $67.2 million in cash and no debt, following a $46.9 million registered direct offering in October 2025.
- +9 more takeaways
Caris Life Sciences Q1 2026 Earnings Call - Revenue Surges 79% on ASP Gains and Profitable MCED Preparations
Caris Life Sciences delivered a forceful start to 2026, with Q1 revenue jumping 79% year-over-year to $216 million, driven by an 85% surge in molecular profiling services. The growth story is no longe...
- Total revenue surged 79% year-over-year to $216 million, driven by an 85% increase in molecular profiling services revenue to $211 million.
- Gross margins expanded dramatically to 65% on a GAAP basis, up from 47% in Q1 2025, reflecting strong pricing power and operating leverage.
- Average selling prices (ASP) for tissue tests jumped 70% to over $4,300, while blood test ASPs rose 14% to just under $2,500.
- +7 more takeaways
Blend Labs Q1 2026 Earnings Call - Autopilot AI Agent Drives Strong Growth and Efficiency
Blend Labs delivered a robust start to 2026, beating revenue and profitability expectations while signaling a strategic pivot toward AI-driven operations. Q1 revenue of $30.8 million grew 15% year-ove...
- Q1 2026 revenue reached $30.8 million, beating the high end of guidance, with 15% year-over-year growth driven by both Mortgage Suite and Consumer Banking suites.
- Non-GAAP operating income was $4.1 million above guidance, yielding a 13% operating margin, up 10 points year-over-year, reflecting strong operating leverage.
- Autopilot, Blend’s AI agent, is live in production with 22 lenders, has processed over 7,000 applications, and is already improving cycle times and conversion rates for early adopters.
- +12 more takeaways
Funko Inc Q1 2025 Earnings Call - Record Margins and Strategic Reset Drive Momentum
Funko delivered a surprisingly strong first quarter, defying the usual seasonal doldrums with a 5% sales increase and a record 44% gross margin. The company is executing a deliberate product reset, cu...
- Total sales rose 5% in Q1, with the core collectibles business jumping 17%, signaling strong momentum entering the year.
- Gross margins hit a record 44%, driven by reduced discounting, renewed licensing deals, and improved channel mix.
- Adjusted EBITDA came in at $11 million, significantly beating management expectations and validating the cost-cutting focus.
- +12 more takeaways
Research Frontiers (RSFQ) Q1 2026 Earnings Call - Gauzy Rehabilitation Plan Gains Momentum Amid Operational Resilience
Research Frontiers navigated a turbulent Q1 2026 marked by accounting headwinds and temporary liquidity freezes tied to Gauzy’s French rehabilitation proceedings. CEO Joe Harary framed the quarter’s s...
- Q1 2026 revenue decline was primarily driven by GAAP accounting timing and the non-recurrence of a 2025 upfront license fee, not weak underlying demand.
- Cash and cash equivalents rose to $1.28 million from $664,000 at year-end 2025, following a targeted financing round with long-term accredited investors.
- Gauzy’s French rehabilitation proceedings temporarily froze payments and slowed revenue recognition, but fund flows are beginning to normalize.
- +12 more takeaways
Reliance Global Group Q1 2026 Earnings Call - Insurance Cash Flow Fuels Strategic Ventures While Milestone-Based Investments Accelerate
Reliance Global Group reported a narrower net loss of $1.4 million in Q1 2026, down from $1.7 million a year earlier, driven by a 11% organic revenue growth in its retained insurance operations and di...
- Net loss narrowed to $1.4 million from $1.7 million in Q1 2025, reflecting improved operating performance and lower interest expense.
- Unrestricted cash increased to $2.3 million from $1.3 million, with total cash and restricted cash rising to $3.2 million.
- Working capital improved to $2.6 million from $1.9 million, and stockholders’ equity grew to $7.4 million from $6.4 million.
- +9 more takeaways
PAR Technology Q1 2026 Earnings Call - AI-Driven Profitability and Guided Growth Take Center Stage
PAR Technology reported a strong Q1 2026, with revenue rising 19% year-over-year to $124 million and adjusted EBITDA jumping 2x to $8.9 million. The company is shedding legacy, low-margin customers to...
- Total revenue grew 19% year-over-year to $124 million, driven by a 15% increase in subscription services and strong hardware demand.
- Adjusted EBITDA surged 2x year-over-year to $8.9 million, reflecting improved cost discipline and operating leverage.
- Management initiated formal Q2 and full-year 2026 guidance, projecting full-year revenue of $500-$515 million and adjusted EBITDA of $44-$47 million.
- +7 more takeaways